Breast Cancer Survivorship Biorepository
Recruiting · NCT05786664 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Southern California
View the official record on ClinicalTrials.gov →Interventions studied
Biospecimen CollectionElectronic Health Record ReviewQuality-of-Life AssessmentSurvey Administration
What this trial is about
This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Women of all racial and ethnic groups 18 years of age or older
- Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
- Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
- Prior participation on clinical trials is allowed
Exclusion criteria
- Current receipt of interventional clinical trial participation
- Stage IV (metastatic) cancer
- Prior history of recurrence (except recurrence following ductal carcinoma in situ)
- Inability to give informed consent
- Unable to speak English, Spanish, Chinese, or Korean
Where it is running
1 location listed across 1 US state.
- USC / Norris Comprehensive Cancer Center - Los Angeles, California, United States